Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept Open-Label Extension in Early Rheumatoid Arthritis
NCT00356590Phase 3Completed
- Sponsor
- Amgen
- Start
- Dec 1998
- Primary completion
- Dec 2008
- Modality
- Fc-Fusion Proteins
01
Overview
A Phase 3 trial of etanercept in rheumatoid arthritis (RA), sponsored by Amgen. Started Dec 1998; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00356590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00356590.